Public German International Broadcaster’s COVID-19 Fact Check: FLCCC a Force to Factor In

Public German International Broadcaster’s COVID-19 Fact Check FLCCC a Force to Factor In

Germany’s state-owned international public broadcaster recently seemingly endorsed Ivermectin as a treatment for COVID-19. Of course, the taxpayer-funded entity known as Deutsche Welle or “DW” isn’t a medical agency and has no authority or credentials to recommend any drug. But they certainly have reach, influenced and are backed by deep pockets. The public broadcaster makes content available in 30 languages from Hindi and Spanish to Arabic and English. Because the content created by DW’s employees are regulated by the Deutsche Welle-Act, its independent of government influence, affording more independence than perhaps available for other comparable public broadcasters. DW quietly released a “Fact Check: Effective (and Ineffective) COVID-19 Treatments.” The international media powerhouse chimed in on Ivermectin.

First, TrialSite finds it interesting that the Remdesivir conflict just gets more controversial. On the one hand, Remdesivir, supported by a series of taxpayer-supported trials via the National Institutes of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) is approved by the U.S. Food and Drug Administration (FDA). TrialSite’s cri...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee